Clinical Trials Browser

NCT07502300 2026-04-14

A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer

Phase 3 Not yet recruiting

562 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07472517 2026-03-31

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy

Phase 3 Not yet recruiting

670 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07001995 2026-03-16

Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression

Phase 2 Not yet recruiting

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

Phase 1/2 Not yet recruiting

596 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07349225 2026-01-16

Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Phase 2 Not yet recruiting

46 enrolled

Thoracic

ES-SCLC

NCT07258147 2025-12-02

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

Phase 2 Not yet recruiting

30 enrolled

Thoracic

Lung Neoplasms

NCT07141771 2025-08-26

An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

Phase 1/2 Not yet recruiting

100 enrolled

Thoracic

SCLC, Extensive Stage

NCT07097948 2025-08-01

Adjuvant

Phase 2 Not yet recruiting

40 enrolled

Thoracic

Recurrence, Small Cell Lung Carcinoma

NCT07083375 2025-07-24

QL1706

Phase 2 Not yet recruiting

56 enrolled

Thoracic

Extensive Small Cell Lung Cancer

NCT07061535 2025-07-11

STAR-SCLC

Phase 2 Not yet recruiting

40 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06931145 2025-04-23

Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

Phase 4 Not yet recruiting

50 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06786312 2025-01-22

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

Phase 2 Not yet recruiting

34 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06732258 2024-12-27

Low-dose Radiotherapy Combined with Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC

Phase 1 Not yet recruiting

12 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06648200 2024-10-18

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Phase 2 Not yet recruiting

100 enrolled

Thoracic

Recurrence, Small Cell Lung Carcinoma

NCT06497530 2024-07-12

Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC

Phase 2 Not yet recruiting

30 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06463171 2024-06-17

Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

60 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06375109 2024-04-19

NeoSCLC-001

Phase 2 Not yet recruiting

60 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06306560 2024-03-12

A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

Phase 2 Not yet recruiting

40 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT05484583 2022-08-05

Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases

Phase 2 Not yet recruiting

58 enrolled

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma